维普期刊资源整合服务平台（V6.5）

89篇 您的检索式：作者名="GASPARO M"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Removal of endogenous leptin from the circulation by the kidney显示文摘	Cumin F Baum HP Gasparo M		0，，：	2
2	Angiotensin Ⅱ - receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction显示文摘	Rogg H de Gasparo M Graedel E	1996	Eur Heart J1996，17，：	1
3	Involvement of the pancreatic renin-angiotensin system in insulin resistance and the metabolic syndrome 显示文摘	Leung P S de Gasparo M	2006	J Cardiometab Syndr2006，1，：	1
4	Involvement of the pancreaticrenin-angiotensin system in insulin resistance and the met-abolic syndrome显示文摘	Leung PS de Gasparo M	2006	J Cardiometab Syndr2006，1，3：	1
5	Subcutaneous and visceral fat distribution ac- cording to sex, age, and overweight, evaluated by compu- ted tomography显示文摘	Enzi G Gasparo M Biondetti PR Fiore D Semisa M Zurlo F	1986	Am J Clin Nutr1986，44，：	1
6	Disparate effects of angiontensin Ⅱantagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension:potential role of nephrin显示文摘	Cao Z de Gasparo M	2003	J Hypertens2003，21，1：	1
7	Binding of valsartan to mammalian angiotensin AT1 receptors显示文摘	De gasparo M Whitebread S	1995	Regul Pept1995，59，：	1
8	Using high-resolution stratigra-phy and structural analysis to constrain polyphase tectonics inwedge-top basins:Inferences from the late Tortonian Scillato Basin(central-northern Sicily)显示文摘	GugliottaC Gasparo MorticelIi M	2012	Sedimentary Geology2012，10，273274：	1
9	Pharmacology of angio-tensin II receptors the kidney显示文摘	DE GASPARO M LEVENS N R	1994	Kidney Int1994，46，9：	1
10	Angiotensin Ⅱ and nitric oxide interaction显示文摘	de GASPARO M	2002	Heart Fail Rev2002，7，4：	1
11	Proposed update of angiotensin receptor nomenclature显示文摘	de Gasparo M Husain A Alexander W	1995	Hypertension1995，25，：	1
12	Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro显示文摘	de Gasparo M Joss U Ramjoue HP	1987	J Pharmacol Exp Ther1987，240，2：	1
13	The angiotensin II receptors 显示文摘	De Gasparo M Catt KJ Inagami T	2000	Pharrnaeol Rev2000，52，3：	1
14	AT1 and AT2 angiotensin 11 receptors:key features显示文摘	De Gasparo M	2002	Drugs2002，62，1：	1
15	Three new epoxy-spironolactone derivatives:characterization in vivo and in vitro显示文摘	de Gasparo M Joss U Ramjoue HP	1987	J Pharmacol Exp Ther1987，240，：	1
16	Combination of non - hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction 显示文摘	Gasparo M Hess P Nuesslein - Hildesheim B	2000	J Renin Angiotensin Aldosterone Syst2000，1，：	1
17	Proposed updateof angiotensin receptor nomenclature 显示文摘	De Gasparo M Husain A Alexander W	1995	Hypertension1995，25，5：	1
18	CGP 38560:orally active,low-molecular-weight renin inhibitor with high potency and specificity显示文摘	Criscione L de Gasparo M	1989	J Cardiovasc Pharmacol1989，14，：	1
19	Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin Ⅱ AT1-receptor subtype显示文摘	Criscione L Gasparo M Buhlmayer P	1993	Br J Pharmacol1993，110，：	1
20	Does blockade of angiotensin II receptors offer clinical benefits over inhibition of angiotensinconverting enzyme? 显示文摘	de GASPARO M LEVENS N	1998	Pharmacol Toxicol1998，82，6：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示